ANKTIVA vs KEYTRUDA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. ANKTIVA and KEYTRUDA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANKTIVA	KEYTRUDA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	nogapendekin alfa inbakicept-pmln	PEMBROLIZUMAB
Manufacturer	Altor Bioscience, LLC, An Indirect Wholly-Owned Su	Merck Sharp Dohme
Dosage forms	Solution	Injectable
Drug class	Interleukin-15 Receptor Agonist	Programmed Death Receptor-1 Blocking Antibody
Boxed warning	None	None
Treats	Urinary Bladder Neoplasms	Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms

anktiva keytruda

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

nogapendekin alfa inbakicept-pmln

PEMBROLIZUMAB

Manufacturer

Altor Bioscience, LLC, An Indirect Wholly-Owned Su

Merck Sharp Dohme

Dosage forms

Solution

Injectable

Drug class

Interleukin-15 Receptor Agonist

Programmed Death Receptor-1 Blocking Antibody

Boxed warning

None

Treats

Urinary Bladder Neoplasms

Malignant Mesothelioma, Biliary Tract Neoplasms, Urinary Bladder Neoplasms

Frequently asked questions

What is the difference between Anktiva and Keytruda?

Anktiva contains Nogapendekin Alfa Inbakicept-Pmln, while Keytruda contains Pembrolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.